At the tumor margin, miR-22 inhibited Rho GTPase signaling, toll-like receptor signaling, trans-Golgi network budding, cell interactions, VEGF, EGFR signaling, and cell cycle signaling, among others. Here, EGFR is linked to neoplasm.